The ∆382 variant of SARS-CoV-2 seems to be associated with a milder infection. The observed clinical effects of deletions in ORF8 could have implications for the...
Dabrafenib plus trametinib combination treatment showed promising activity in patients with BRAFV600E-mutated biliary tract cancer, with a manageable safety profile. Routine testing for BRAFV600E mutations should...
As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there have been increasing reports from Europe, North America, Asia, and Latin America describing children...
Acute kidney injury is a commonly described complication of COVID-19 that has been linked to increased morbidity and mortality. Although severe acute respiratory syndrome coronavirus 2...
Lubiprostone was well tolerated and reduced the levels of liver enzymes in patients with NAFLD and constipation. Further studies are necessary to better define the efficacy...
The COVID-19 global pandemic continues to have devastating health, economic, and social effects, and is profoundly affecting the delivery of health services. Because of the infection...
The Personal View by Euzebiusz Jamrozik and Michael Selgelid1 was helpful in laying out some of the key ethical issues with human challenge trials for COVID-19....
On Dec 31, 2019, the Wuhan Municipal Health Commission (Wuhan, China), reported a cluster of cases of pneumonia to WHO. A novel coronavirus was identified—severe acute...
As the initial phase of the COVID-19 pandemic passes its peak in many countries, serological studies are becoming increasingly important in guiding public health responses. Antibody...
To prevent a second COVID-19 wave, relaxation of physical distancing, including reopening of schools, in the UK must be accompanied by large-scale, population-wide testing of symptomatic...